2024/11/01 08:01:27 | |
---|---|
Price | |
30.65 EUR | |
Difference | -0.13% (-0.04) |
ISIN | JP3160400002 |
Symbol | 4523 |
Exchange | Hanover |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8,769 EUR |
Benchmark | NIKKEI 225 |
Bid (Bid size) | 30.72 EUR (163) |
Ask (Ask size) | 31.04 EUR (162) |
Open | 30.65 EUR |
High | 30.65 EUR |
Low | 30.65 EUR |
Close (prev. day) | 30.69 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/10/29 | Global Equity Ratings | ||
2024/10/29 | Aktienempfehlungen Global | ||
2024/10/22 | Global Equity Ratings | ||
2024/10/22 | Aktienempfehlungen Global | ||
2024/10/14 | Aktienempfehlungen Österreich |
2024/11/01 08:01:27 | |
---|---|
Price | |
30.65 EUR | |
Difference | -0.13% (-0.04) |
ISIN | JP3160400002 |
Symbol | 4523 |
Exchange | Hanover |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8,769 EUR |
Benchmark | NIKKEI 225 |
Bid (Bid size) | 30.72 EUR (163) |
Ask (Ask size) | 31.04 EUR (162) |
Open | 30.65 EUR |
High | 30.65 EUR |
Low | 30.65 EUR |
Close (prev. day) | 30.69 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6M | 1Y | 3Y | |
Perf (%) | -19.72% | -37.81% | -48.85% |
Perf (abs.) | -7.54 | -18.66 | -29.31 |
Beta | 0.45 | 0.44 | 0.55 |
Volatility | 33.98 | 30.63 | 45.84 |
Ø price 5 days | Ø volume 5 days (pcs.) | 31.35 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 33.06 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 35.67 EUR (3) |
Ø price 250 days | Ø volume 250 days (pcs.) | 39.00 EUR (2) |
YTD High | date | 47.43 EUR (2024/01/11) |
YTD Low | date | 30.65 EUR (2024/10/23) |
52 Weeks High | date | 50.34 EUR (2023/11/02) |
52 Weeks Low | date | 30.65 EUR (2024/10/23) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/10/31 | 22:26 | 30.93 EUR | 0.01 | 7 |
Tokyo Stock Exchange | 2024/11/01 | 07:00 | 5,075.00 JPY | 69.77 | 4,009 |
Stuttgart | 2024/11/01 | 08:13 | 30.16 EUR | 0.00 | 1 |
Munich | 2024/11/01 | 08:03 | 30.83 EUR | 0.00 | 1 |
Hanover | 2024/11/01 | 08:01 | 30.65 EUR | 0.00 | 1 |
Frankfurt | 2024/11/01 | 08:20 | 30.25 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2024/10/30 | 17:26 | 32.77 USD | 0.02 | 2 |
Duesseldorf | 2024/11/01 | 12:30 | 30.59 EUR | 0.00 | 3 |
Berlin | 2024/11/01 | 08:04 | 30.61 EUR | 0.00 | 1 |
EISAI CO. LTD. |
- - |
4-6-10 Koishikawa, Bunkyo-Ku - 112-8088 Tokyo |
Telefon: +81-3-3817-3030 |
Fax: + |
E-mail: - |
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan. |
Haruo Naito | Chairman of Managing Board |
Akiko Nakahama | Member of Executive Committee |
Gary Hendler | Member of Executive Committee |
Ivan Cheung | Member of Executive Committee |
Kazuhiko Tamura | Member of Executive Committee |
Keisuke Naito | Member of Executive Committee |
Kenta Takahashi | Member of Executive Committee |
Lynn Kramer | Member of Executive Committee |
Masatomi Akana | Member of Executive Committee |
Mitsuo Kosaka | Member of Executive Committee |
Mitsuru Shomon | Member of Executive Committee |
Sayoko Sasaki | Member of Executive Committee |
Shin Ujiie | Member of Executive Committee |
Shohei Kanazawa | Member of Executive Committee |
Takashi Owa | Member of Executive Committee |
Tatsuyuki Yasuno | Member of Executive Committee |
Terushige Iike | Member of Executive Committee |
Teruyuki Masaka | Member of Executive Committee |
Toshitaka Asano | Member of Executive Committee |
Yanhui Feng | Member of Executive Committee |
Yasushi Okada | Member of Executive Committee |
Clive Thornley | Member of Supervisory Board |
Fumihiko Ike | Member of Supervisory Board |
Hiroyuki Kato | Member of Supervisory Board |
Kanai Sawaji | Member of Supervisory Board |
Kenta Takahashi | Member of Supervisory Board |
Ryota Miura | Member of Supervisory Board |
Toru Moriyama | Member of Supervisory Board |
Yoshiteru Kato | Member of Supervisory Board |
Yuko Yasuda | Member of Supervisory Board |
Yumiko Miwa | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.